221 related articles for article (PubMed ID: 23184827)
1. Well-defined degradable cationic polylactide as nanocarrier for the delivery of siRNA to silence angiogenesis in prostate cancer.
Chen CK; Law WC; Aalinkeel R; Nair B; Kopwitthaya A; Mahajan SD; Reynolds JL; Zou J; Schwartz SA; Prasad PN; Cheng C
Adv Healthc Mater; 2012 Nov; 1(6):751-61. PubMed ID: 23184827
[TBL] [Abstract][Full Text] [Related]
2. Nanotherapy silencing the interleukin-8 gene produces regression of prostate cancer by inhibition of angiogenesis.
Aalinkeel R; Nair B; Chen CK; Mahajan SD; Reynolds JL; Zhang H; Sun H; Sykes DE; Chadha KC; Turowski SG; Bothwell KD; Seshadri M; Cheng C; Schwartz SA
Immunology; 2016 Aug; 148(4):387-406. PubMed ID: 27159450
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells.
Chen CK; Law WC; Aalinkeel R; Yu Y; Nair B; Wu J; Mahajan S; Reynolds JL; Li Y; Lai CK; Tzanakakis ES; Schwartz SA; Prasad PN; Cheng C
Nanoscale; 2014; 6(3):1567-72. PubMed ID: 24326457
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of cationic polylactides with tunable charge densities as nanocarriers for effective gene delivery.
Jones CH; Chen CK; Jiang M; Fang L; Cheng C; Pfeifer BA
Mol Pharm; 2013 Mar; 10(3):1138-45. PubMed ID: 23339525
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable nanocapsules as siRNA carriers for mutant K-Ras gene silencing of human pancreatic carcinoma cells.
Lin G; Hu R; Law WC; Chen CK; Wang Y; Li Chin H; Nguyen QT; Lai CK; Yoon HS; Wang X; Xu G; Ye L; Cheng C; Yong KT
Small; 2013 Aug; 9(16):2757-63. PubMed ID: 23427041
[TBL] [Abstract][Full Text] [Related]
6. Poly(ethylene glycol)-block-cationic polylactide nanocomplexes of differing charge density for gene delivery.
Chen CK; Jones CH; Mistriotis P; Yu Y; Ma X; Ravikrishnan A; Jiang M; Andreadis ST; Pfeifer BA; Cheng C
Biomaterials; 2013 Dec; 34(37):9688-99. PubMed ID: 24034497
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-8 gene silencing on pancreatic cancer cells using biodegradable polymer nanoplexes.
Lin G; Yang C; Hu R; Chen CK; Law WC; Anderson T; Zhang B; Nguyen QT; Toh HT; Yoon HS; Cheng C; Yong KT
Biomater Sci; 2014 Jul; 2(7):1007-1015. PubMed ID: 32481974
[TBL] [Abstract][Full Text] [Related]
8. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics.
Takei Y; Kadomatsu K; Yuzawa Y; Matsuo S; Muramatsu T
Cancer Res; 2004 May; 64(10):3365-70. PubMed ID: 15150085
[TBL] [Abstract][Full Text] [Related]
9. Synthetic poly(ester amine) and poly(amido amine) nanoparticles for efficient DNA and siRNA delivery to human endothelial cells.
Tzeng SY; Yang PH; Grayson WL; Green JJ
Int J Nanomedicine; 2011; 6():3309-22. PubMed ID: 22228998
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional triblock Nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing.
Patil ML; Zhang M; Minko T
ACS Nano; 2011 Mar; 5(3):1877-87. PubMed ID: 21322531
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable nano-polymeric system for efficient Akt1 siRNA delivery.
Jere D; Arote R; Jiang HL; Kim YK; Cho MH; Cho CS
J Nanosci Nanotechnol; 2010 May; 10(5):3366-9. PubMed ID: 20358958
[TBL] [Abstract][Full Text] [Related]
12. The development of ternary nanoplexes for efficient small interfering RNA delivery.
Şalva E; Turan SÖ; Akbuğa J
Biol Pharm Bull; 2013; 36(12):1907-14. PubMed ID: 24432377
[TBL] [Abstract][Full Text] [Related]
13. Aerosol delivery of stabilized polyester-siRNA nanoparticles to silence gene expression in orthotopic lung tumors.
Yan Y; Zhou K; Xiong H; Miller JB; Motea EA; Boothman DA; Liu L; Siegwart DJ
Biomaterials; 2017 Feb; 118():84-93. PubMed ID: 27974266
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional triblock co-polymer mP3/4HB-b-PEG-b-lPEI for efficient intracellular siRNA delivery and gene silencing.
Zhou L; Chen Z; Wang F; Yang X; Zhang B
Acta Biomater; 2013 Apr; 9(4):6019-31. PubMed ID: 23295402
[TBL] [Abstract][Full Text] [Related]
15. Designing idiosyncratic hmPCL-siRNA nanoformulated capsules for silencing and cancer therapy.
Kumar VB; Medhi H; Yong Z; Paik P
Nanomedicine; 2016 Apr; 12(3):579-588. PubMed ID: 26554393
[TBL] [Abstract][Full Text] [Related]
16. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
18. Assembling Mn:ZnSe quantum dots-siRNA nanoplexes for gene silencing in tumor cells.
Wang Y; Yang C; Hu R; Toh HT; Liu X; Lin G; Yin F; Yoon HS; Yong KT
Biomater Sci; 2015 Jan; 3(1):192-202. PubMed ID: 26214202
[TBL] [Abstract][Full Text] [Related]
19. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481
[TBL] [Abstract][Full Text] [Related]
20. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer.
Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
J Control Release; 2008 Jul; 129(2):107-16. PubMed ID: 18486981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
